Untitled

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, with fatigue: a 18F-fluorodeoxyglucose positron Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its study. Neurology 1997;48:1566-71. definition and study. International Chronic 12. Tirelli U, Chierichetti F, Tavio M, Simonelli C, Fatigue Syndrome Study Group. Ann Intern Med Bianchin G, Zanco P, et al. Brain positron emission tomography (PET) in chronic fatigue 2. Chaudhuri A, Watson WS, Pearn J, Behan PO. syndrome: preliminary data. Am J Med The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med 13. Bell DA. The Doctor’s Guide to Chronic 3. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical 14. Stimmel B. Pain and its relief without conditions. Ann Intern Med 2001;134:868-81. addiction. New York: Hayworth Medical Press; Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol mechanisms of the spinal cord. 2 ed. NY: Plenum 5. Gow JW, Behan WM, Simpson K, McGarry F, Keir S, Behan PO. Studies on enterovirus in mechanisms modulating painrelated information: patients with chronic fatigue syndrome. Clin Do they become deficient after lesions of the Infect Dis 1994;18 Suppl 1:S126-9. peripheral or central nervous system. New York: identification of enteroviral sequences in the 17. Raj PP. Pain medicine: A comprehensive postviral fatigue syndrome. Br Med Bull 18. Henriksson KG. Aspects of the pathogenesis 7. Kurastune H, et al. Acylcarnitine deficiency in of chronic muscular pain. Journal of chronic fatigue syndrome. Clinical Infectious Musculoskeletal Pain 1995;3:35-41. 19. Russell IJ, Michalek JE, Vipraio GA, Fletcher 8. Somjen G. Neurophysiology-the essentials. Baltimore: Williams & Wilkins; 1983. 3H-imipramine uptake receptor density and 9. Greco A, Tannock C, Brostoff J, et al. Brain MR in chronic fatigue syndrome. American fibromyalgia/fibrositis syndrome. J Rheumatol Journal of Neuroradiology 1997;18:1265-69. 10. Dickinson CJ. Chronic fatigue 20. Russell IJ, Vaeroy H, Javors M, Nyberg F. syndrome--aetiological aspects. Eur J Clin Invest Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid 11. Roelcke U, Kappos L, Lechner-Scott J, arthritis. Arthritis Rheum 1992;35:550-6. Brunnschweiler H, Huber S, Ammann W, et al. Reduced glucose metabolism in the frontal cortex pathophysiology of fibromyalgia: Abberant and basal ganglia of multiple sclerosis patients Journal of Rheumatology between CFS patients and healthy sedentary controls [abstract]. J Chronic Fatigue Syndrome 22. Dubner R, Bennett GJ. Spinal and trigeminal mechanisms of nociception. Annu Rev Neurosci 31. Riley MS, O’Brien CJ, McCluskey DR, Bell NP, Nicholls DP. Aerobic work capacity in patients with chronic fatigue syndrome. BMJ pain-modulating networks (biogenic amines and nonopioid analgesics). In: Fields HL, Dubner R, 32. Saltin B, Blomqvist G, Mitchell JH, Johnson Cervero F, editors. Advances in Pain Research RL, Jr., Wildenthal K, Chapman CB. Response to exercise after bed rest and after training. peptides and the modulation of pain: 33. Montgomery I, Trinder J, Paxton SJ. Energy immunohistochemical analysis of dynorphin and expenditure and total sleep time: effect of enkephalin in the trigeminal nucleus caudalis and physical exercise. Sleep 1982;5:159-68. spinal cord of the cat. J Comp Neurol 34. Harma MI, Ilmarinen J, Knauth P, Rutenfranz J, Hanninen O. Physical training intervention in 25. Demitrack MA, Crofford LJ. Evidence for female shift workers: II. The effects of and pathophysiologic implications of intervention on the circadian rhythms of alertness, dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998;840:684-97. 35. George MS, Ketter TA, Post RM. SPECT and 26. Demitrack MA, Dale JK, Straus SE, Laue L, PET imaging in mood disorders. J Clin Listwak SJ, Kruesi MJ, et al. Evidence for impaired activation of the hypothalamicpituitary- adrenal axis in patients with chronic fatigue Neurobiology of CFS. Oxford: Oxford University J Clin Endocrinol Metab Press; 1998. 37. Goldstein JA. Chronic Fatigue Syndromes: 27. Cleare AJ, Bearn J, Allain T, McGregor A, The Limbic Hypothesis. New York: Haworth Wessely S, Murray RM, et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord Glabus MF, Murray CL, Goodwin GM, et al. Cerebral perfusion in chronic fatigue syndrome 28. Poteliakhoff A. Adrenocortical activity and and depression. Br J Psychiatry 2000;176:550-6. some clinical findings in acute and chronic 39. Costa DC, Tannock C, Brostoff J. Brainstem fatigue. J Psychosom Res 1981;25:91-5. perfusion is impaired in chronic fatigue syndrome. 29. Leese G, Chattington P, Fraser W, et al. Short-term night-shift working mimics the 40. Whiting P, Bagnall A-M, Sowden AJ, Cornell pituitary-adrenocortical dysfunction of chronic JE, et al. Interventions for the treatment and fatigue syndrome. Journal of Clinical Endocrinol management of chronic fatigue syndrome. JAMA 30. Fulcher KY, White PD. A comparison of 41. DeMeirleir K, Bisbal C, Campine I, et al. A physiological and psychological parameters 37 kDa 25A binding protein as a potential biochemical marker for chronic fatigue syndrome. 51. Lerner AM, Goldstein J, Chang C, et al. 42. Buchwald D, Garrity D. Comparison of Cardiac involvement in patients with chronic patients with chronic fatigue syndrome, fatigue syndrome as documented with Holter and fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994;154:2049-53. 1991-1993. Infect Dis Clin Prac 1997;6:327-33. 43. Lloyd AR, Hickie I, Peterson PK. Chronic 52. Kort JJ, Jalonen TO. The nef protein of the fatigue syndrome: current concepts of human immunodeficiency virus type 1 (HIV-1) pathogenesis and treatment. Curr Clin Top Infect inhibits a large-conductance potassium channel in human glial cells. Neurosci Lett 1998;251:1-4. 44. Suhadolnik RJ, Reichenbach NL, Hitzges P, 53. Fukuda J, Kurata T. Loss of membrane excitability after herpes simplex virus infection in Upregulation of the 2-5A synthetase/RNase L tissue-cultured nerve cells from adult mammals. antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994;18 Suppl 54. Soave R. Cyclospora: an overview. Clin Infect 45. Suhadolnik RJ, Peterson DL, O’Brien K, 55. Renfro L, Feder HM, Jr., Lane TJ, Manu P, Cheney PR, Herst CV, Reichenbach NL, et al. Biochemical evidence for a novel low molecular patients with chronic fatigue. Am J Med weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 56. Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, et al. A controlled clinical 46. Natelson BH, Ye N, Moul DE, Jenkins FJ, trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. anti-Epstein-Barr virus DNA polymerase are Clin Infect Dis 1994;18 Suppl 1:S88-95. found in patients with severe fatiguing illness. J 57. Hersey P, Edwards A. Effect of isoprinosine on natural killer cell activity of blood 47. Mawle AC, Nisenbaum R, Dobbins JG, Gary mononuclear cells in vitro and in vivo. Int J Seroepidemiology of chronic fatigue syndrome: a 58. Simon LN, Glasky AJ. Isoprinosine: an case-control study. Clin Infect Dis overview. Cancer Treat Rep 1978;62:1963-9. 48. Reeves WC, Stamey FR, Black JB, Mawle AC, Stewart JA, Pellett PE. Human herpesviruses anti-tumor necrosis factor -alpha therapy. Ann case-control study. Clin Infect Dis 2000;31:48-52. 60. Goldenberg DL. Fibromyalgia and its relation 49. French HW. A Postmodern Plague Ravages to chronic fatigue syndrome, viral illness, and Japan’s Workers. NY Times. East Coast ed. NY; immune abnormalities. J Rheumatol 50. Lerner AM, Zervos M, Dworkin HJ, Chang 61. Goldenberg DL. Fibromyalgia syndrome. CH, O’Neill W. A Unified Theory of the Cause of Chronic Fatigue Syndrome. Infect Dis Clin Prac 62. Komaroff AL. A 56-year-old woman with delivery to muscle in chronic fatigue syndrome. Clin Sci (Colch) 1999;97:603-8; discussion 63. Komaroff AL, Goldenberg D. The chronic fatigue syndrome: definition, current studies and 74. Salerno A, Thomas E, Olive P, Blotman F, lessons for fibromyalgia research. J Rheumatol dysfunction disclosed by single and double 64. Komaroff AL. Clinical presentation of chronic fatigue syndrome. Ciba Found Symp 65. Scott LV, Teh J, Reznek R, Martin A, Sohaib 75. Brickman AL, Fins AI. Psychological and A, Dinan TG. Small adrenal glands in chronic cognitive aspects of chronic fatigue syndrome. In: fatigue syndrome: a preliminary computer Goodnick PJ, Klimas N, editors. Chronic Fatigue tomography study. Psychoneuroendocrinology and Related Immune Deficiency Syndromes. Washington and London: APPI; 1993. p. 67-94. 66. Gillin JC. Sleep studies in affective illness. Psychiatric Annals 1983;13:367-84. Goldstein J, Fidler F. Memory deficits associated Bewick DJ, Horacek BM. Cardiac function at rest syndrome. Biol Psychiatry 1993;33:618-23. and with exercise in the chronic fatigue syndrome. Cornblatt B, Peterson PK, Callies A, et al. An 68. Kent-Braun JA, Sharma KR, Weiner MW, assessment of cognitive function and mood in Massie B, Miller RG. Central basis of muscle chronic fatigue syndrome. Biol Psychiatry fatigue in chronic fatigue syndrome. Neurology 78. Marshall PS, Forstot M, Callies A, Peterson 69. Plioplys AV, Plioplys S. Serum levels of PK, Schenck CH. Cognitive slowing and working carnitine in chronic fatigue syndrome: clinical memory difficulties in chronic fatigue syndrome. correlates. Neuropsychobiology 1995;32:132-8. 70. Sisto SA, LaManca J, Cordero DL, Bergen 79. Gordon R, Michalewski HJ, Nguyen T, Gupta MT, Ellis SP, Drastal S, et al. Metabolic and S, Starr A. Cortical motor potential alterations in cardiovascular effects of a progressive exercise chronic fatigue syndrome. Int J Mol Med test in patients with chronic fatigue syndrome. 80. Grace GM, Nielson WR, Hopkins M, Berg 71. Borman P, Celiker R, Hascelik Z. Muscle MA. Concentration and memory deficits in performance in fibromyalgia syndrome. patients with fibromyalgia syndrome. J Clin Exp 72. Hakkinen A, Hakkinen K, Hannonen P, Alen Manic-Depressive Illness. New York and Oxford: neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from 82. Jimerson DC, Insel TR, Reus VI, Kopin IJ. those of healthy women. J Rheumatol Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch 73. McCully KK, Natelson BH. Impaired oxygen 83. Demitrack MA, Gold PW, Dale JK, Krahn 91. Klein R, Berg PA. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine cerebrospinal fluid monoamine metabolism in in patients with fibromyalgia syndrome and patients with chronic fatigue syndrome: tryptophan-induced eosinophilia-myalgia preliminary findings. Biol Psychiatry syndrome. Clin Investi 1994;72:541-9. 84. Sarrias MJ, Martinez E, Celada P, et al. Papadopoulos E, Brucksch C, Masterson L, Plasma free 5HT and platelet 5HT in depression: Engelberg NC, et al. Melatonin levels in women case-control studies and the effect of with fibromyalgia and chronic fatigue syndrome. antidepressant therapy. In: Schwarcz R, editor. Kynurenine and Serotonin Pathways. New York: 93. Citera G, Arias MA, Maldonado-Cocco JA, Lazaro MA, Rosemffet MG, Brusco LI, et al. The 85. Ellis PM, Salmond C. Is platelet imipramine effect of melatonin in patients with fibromyalgia: binding reduced in depression? A meta-analysis. a pilot study. Clin Rheumatol 2000;19:9- 13. 86. Russell IJ, Bowden CL, Michalek J, et al. Increased concentrations of nerve growth factor Imipramine receptor density on platelets with fibrositis syndrome: Correlation to disease fibromyalgia. J Rheumatol 1999;26:1564-9. severity and response to therapy. Arthritis Rheum 95. Demitrack MA. Neuroendocrine research strategies in chronic fatigue syndrome. In: Goodnick PJ, Klimas N, editors. Chronic Fatigue and Related Immune Deficiency Syndromes. 87. Kravitz HM, Katz R, Kot E, Helmke N, Washington and London: APPI; 1993. p. 45-66. Fawcett J. Biochemical clues to a 96. Scott LV, Dinan TG. The neuroendocrinology fibromyalgia-depression link: imipramine binding of chronic fatigue syndrome: focus on the in patients with fibromyalgia or depression and in hypothalamic-pituitary-adrenal axis. Funct healthy controls. J Rheumatol 1992;19:1428-32. 88. Ernberg M, Lundeberg T, Kopp S. Pain and 97. Scott LV, Dinan TG. Urinary free cortisol allodynia/ hyperalgesia induced by intramuscular excretion in chronic fatigue syndrome, major injection of serotonin in patients with depression and in healthy volunteers. J Affect fibromyalgia and healthy individuals. Pain 98. Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG. Differences in adrenal steroid profile Glatzeder K, Stratz T, Schwarz M, et al. The in chronic fatigue syndrome, in depression and in T102C polymorphism of the 5-HT2Areceptor health. J Affect Disord 1999;54:129-37. gene in fibromyalgia. Neurobiol Dis 99. De Becker P, De Meirleir K, Joos E, Campine 90. Klein R, Bansch M, Berg PA. Clinical Dehydroepiandrosterone (DHEA) response to i.v. relevance of antibodies against serotonin and ACTH in patients with chronic fatigue syndrome. gangliosides in patients with primary Horm Metab Res 1999;31:18-21. 100. Scott LV, Medbak S, Dinan TG. The low Psychoneuroendocrinology 1992;17:593-8. dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998;48:733-7. Cognitive functioning and magnetic resonance 101. Scott LV, Medbak S, Dinan TG. Blunted imaging in chronic fatigue. Br J Psychiatry adrenocorticotropin and cortisol responses to corticotropin- releasing hormone stimulation in 110. Kwiatek R, Barnden L, Tedman R, Jarrett R, chronic fatigue syndrome. Acta Psychiatr Scand Chew J, Rowe C, et al. Regional cerebral blood flow in fibromyalgia: single-photonemission 102. Adler GK, Kinsley BT, Hurwitz S, Mossey computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis hypothalamic-pituitary and sympathoadrenal Rheum 2000;43:2823-33. fibromyalgia syndrome. Am J Med Neuroimmune relations in patients with fibromyalgia: a positron emission tomography 103. Leal-Cerro A, Povedano J, Astorga R, study. Neurosci Lett 2000;282:193-6. Gonzalez M, Silva H, Garcia- Pesquera F, et al. The growth hormone (GH)-releasing hormone- Depression, the immune system, and health and GH-insulin-like growth factor- 1 axis in patients illness. Findings in search of meaning. Arch Gen with fibromyalgia syndrome. J Clin Endocrinol 113. Lloyd AR, Wakefield D, Hickie I. Immunity 104. Cleare AJ, Sookdeo SS, Jones J, O’Keane V, and the pathophysiology of chronic fatigue Miell JP. Integrity of the growth syndrome. Ciba Found Symp 1993;173:176-87; hormone/insulin-like growth factor system is maintained in patients with chronic fatigue 114. Barker E, Fujimura SF, Fadem MB, Landay associated with chronic fatigue syndrome. Clin Infect Dis 1994;18 Suppl 1:S136-41. 115. Nasralla M, Haier J, Nicolson GL. Multiple intolerance in adolescent chronic fatigue mycoplasmal infections detected in blood of syndrome. Pediatrics 1999;103:116-21. patients with chronic fatigue syndrome and/or 106. Schondorf R, Benoit J, Wein T, Phaneuf D. fibromyalgia syndrome. Eur J Clin Microbiol Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999;75:192-201. 116. Wallace HL, 2nd, Natelson B, Gause W, Hay 107. LaManca JJ, Peckerman A, Walker J, Kesil J. Human herpesviruses in chronic fatigue W, Cook S, Taylor A, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999;19:111-20. 117. Goodnick PJ, Sandoval R. Treatment of 108. Schwartz RB, Komaroff AL, Garada BM, chronic fatigue syndrome and related disorders: Gleit M, Doolittle TH, Bates DW, et al. SPECT immunological approaches. In: Goodnick PJ, imaging of the brain: comparison of findings in Klimas N, editors. Chronic Fatigue and Related patients with chronic fatigue syndrome, AIDS Immune Deficinecy Disorders. Washington and dementia complex, and major unipolar depression. 118. Straus SE, Dale JK, Tobi M, Lawley T, 109. Cope H, Pernet A, Kendall B, David A. Preble O, Blaese RM, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy Studies of Neuromuscular Disease. Orange, in a placebo-controlled trial. N Engl J Med 128. Plioplys AV, Plioplys S. Amantadine and 119. DuBois RE. Gamma globulin therapy for L-carnitine treatment of Chronic Fatigue chronic mononucleosis syndrome. AIDS Res Syndrome. Neuropsychobiology 1997;35:16-23. 129. McKenzie R, O’Fallon A, Dale J, Demitrack 120. Peterson PK, Shepard J, Macres M, Schenck C, Crosson J, Rechtman D, et al. A controlled trial hydrocortisone for treatment of chronic fatigue of intravenous immunoglobulin G in chronic syndrome: a randomized controlled trial. JAMA fatigue syndrome. Am J Med 1990;89:554- 60. 121. Lloyd A, Hickie I, Wakefield D, Boughton C, 130. Cleare AJ, Heap E, Malhi GS, Wessely S, Dwyer J. A doubleblind, placebo-controlled trial O’Keane V, Miell J. Low-dose hydrocortisone in of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J crossover trial. Lancet 1999;353:455-8. 131. Scharf MB, Hauck M, Stover R, McDannold 122. Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the gamma-hydroxybutyrate on pain, fatigue, and the postviral fatigue syndrome. Acta Neurol Scand alpha sleep anomaly in patients with fibromyalgia. 123. Sklar SH. Old drug with new application being tested as CEBV remedy. Chronic Fatigue 132. Forsyth LM, Preuss HG, MacDowell AL, Immune Defficiency Sydrome 1988:6-7. Chiazze L, Jr., Birkmayer GD, Bellanti JA. 124. Peterson DL, Strayer DR, Bastein S, et al. Clinical improvements obtained with Ampligen symptoms of patients with chronic fatigue in patients with severe chronic fatigue syndrome syndrome. Ann Allergy Asthma Immunol and associated encephalopathy. In: Hyde B, editor. The Clinical and Scientific Basis of Myalgic 133. Warren G, McKendrick M, Peet M. The role Encephalitis / Chronic Fatigue Syndrome. of essential fatty acids in chronic fatigue Ottawa: Nightingale Research Foundation; 1992. syndrome. A case- controlled study of red-cell membrane essential fatty acids (EFA) and a placebocontrolled treatment study with high dose of EFA. Acta Neurol Scand 1999;99:112-6. 134. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. 125. Kaslow JE, Rucker L, Onishi R. Liver The relationship between neurally mediated extract-folic acidcyanocobalamin vs placebo for hypotension and the chronic fatigue syndrome. chronic fatigue syndrome. Arch Intern Med 135. Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, et al. Fludrocortisone treatment of CFIDS with kutapressin. Chronic acetate to treat neurally mediated hypotension in Fatigue Immune Defficiency Sydrome chronic fatigue syndrome: a randomized controlled trial. JAMA 2001;285:52-9. 127. Ericsson AD. Oral Alpha Interferon: Clinical 136. Goodnick PJ, Sandoval R. Psychotropic treatment of chronic fatigue syndrome and related Policastro T, Findley TW. Randomized, double disorders. J Clin Psychiatry 1993;54:13-20. blind, controlled placebo-phase in trial of low 137. Wysenbeek AJ, Mor F, Lurie Y, Weinberger dose phenelzine in the chronic fatigue syndrome. A. Imipramine for the treatment of fibrositis: a Psychopharmacology (Berl) 1996;124:226-30. therapeutic trial. Ann Rheum Dis 1985;44:752-3. 148. Natelson BH, Cheu J, Hill N, Bergen M, 138. Carette S, Oakson G, Guimont C, Steriade M. Korn L, Denny T, et al. Single-blind, placebo Sleep electroencephalography and the clinical phase-in trial of two escalating doses of selegiline response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995;38:1211-7. Neuropsychobiology 1998;37:150-4. 139. Carette S, McCain GA, Bell DA, Fam AG. 149. Hickie IB, Wilson AJ, Wright JM, Bennett Evaluation of amitriptyline in primary fibrositis. BK, Wakefield D, Lloyd AR. A randomized, A double-blind, placebo-controlled study. double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue 140. Goldenberg DL, Felson DT, Dinerman H. A syndrome. Br J Clin Psychiatry 2000;61:643-8. randomized, controlled trial of amitriptyline and 150. Goodnick PJ. Bupropion in chronic fatigue naproxen in the treatment of patients with syndrome. Am J Psychiatry 1990;147:1091. fibromyalgia. Arthritis Rheum 1986;29:1371-7. 151. Goodnick PJ, Sandoval R, Brickman A, Harth M. Improvements in pain responsiveness in fluoxetine-resistant chronic fatigue syndrome. patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989;16 Suppl 152. Geller SA. Treatment of fibrositis with fluoxetine hydrochloride (Prozac). Am J Med 142. Gracious B, Wisner KL. Nortriptyline in chronic fatigue syndrome: a double blind, 153. Finestone DH, Ober SK. Fluoxetine and placebo- controlled single case study. Biol fibromyalgia. JAMA 1990;264:2869-70. 154. Klimas NG, Morgan R, Van Riel F, et al. 143. Bibolotto E, Borghi C, Paculli E, et al. The Observations regarding use of an antidepressant management of fibrositis: a double-blind fluoxetine in chronic fatigue syndrome. In: comparison of maprotyline, clomipramine, and Goodnick PJ, Klimas NG, editors. Chronic placebo. Clinical Trials Journal 1986;23:269-80. 144. Malley PG, Jackson JL, Santoro J, et al. Disorders. Washington and London: APPI; 1993. Antidepressant therapy for unexplained p. 85-108. symptoms and symptom syndromes. J Fam Pract Antidepressant therapy in the chronic fatigue syndrome. Br J Gen Pract 1991;41:339-42. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol patients with chronic fatigue syndrome. Drugs 157. Vercoulen JH, Swanink CM, Zitman FG, 147. Natelson BH, Cheu J, Pareja J, Ellis SP, Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. placebo-controlled study. Arthritis Rheum 158. Syuertsen R. Sertraline treatment of fibromyalgia. Paper presented at: 8th ENCP 169. Tavoni A, Vitali C, Bombardier S, Pasero G. meeting; September 20th - October 4th, 1995; Evaluation of Sadenosylmethionine in primary fibromyalgia. A double-blind crossover study. Am 159. Behan PO, Haniffah BAG, Doogan DP, et al. A pilot study of sertraline for the treatment of 170. Caruso I, Sarzi Puttini P, Cazzola M, chronic fatigue syndrome. Clin Infect Dis 5-hydroxytryptophan versus placebo in the 160. Norregaard J, Volkmann H, treatment of primary fibromyalgia syndrome. J Danneskiold-Samsoe B. A randomized controlled 171. Puttini PS, Caruso I. Primary fibromyalgia fibromyalgia. Pain 1995;61:445-9. syndrome and 5-hydroxy-L-tryptophan: a 90-day 161. Anderberg UM, Marteinsdottir I, von open study. J Int Med Res 1992;20:182-9. 172. Tyber MA. Lithium carbonate augmentation fibromyalgia--a randomized, double-blind, therapy in fibromyalgia. CMAJ 1990;143:902-4. placebocontrolled study. Eur J Pain 173. Masand PS, Tesar GE. Use of stimulants in the medically ill. Psychiatric Clinics of North 162. Goodnick PJ. Treatment of chronic fatigue syndrome with venlafaxine. Am J Psychiatry 174. Gerner R. Systematic treatment approach to depression and treatment resistant depression. Psychiatric Annals 1983;13:37-49. Metzger R, Morris-Park E, Keck PE, Jr. An open 175. Stoll AL, Pillay SS, Diamond L, Workum clinical trial of venlafaxine treatment of SB, Cole JO. Methylphenidate augmentation of fibromyalgia. Psychosomatics 1998;39:14-17. serotonin selective reuptake inhibitors: a case 164. Dyson E. Venlafaxine and fibromyalgia. NZ series. J Clin Psychiatry 1996;57:72-6. 176. Menza MA, Kaufman KR, Castellanos A. 165. Goodnick PJ, Jorge CM. Treatment of Modafinil augmentation of antidepressant chronic fatigue syndrome with nefazodone. Am J treatment in depression. J Clin Psychiatry 166. Hickie I. Nefazodone for patients with 177. Disdier P, Genton P, Milandre C, Bernard chronic fatigue syndrome. Aust N Z J Psychiatry PM, Millet Y. Fibrositis syndrome and narcolepsy. 167. Papadopoulos IA, Georgiou PE, Katsimbri 178. McEntee W, Oxman T, Ko G, et al. The effects of sertraline on cognition in depressed Treatment of fibromyalgia with tropisetron, a geriatric patients. NCDEU Annual Meeting. Boca 5HT3 serotonin antagonist: a pilot study. Clin 179. Grafman J. Neuropsychological Features of 168. Russell IJ, Fletcher EM, Michalek JE, Chronic Fatigue Syndrome. In: Straus SE, McBroom PC, Hester GG. Treatment of primary Hawton K, Salkovskis P, et al, editors. Chronic fibrositis/fibromyalgia syndrome with ibu-profen 190. Manu P, Lane TJ, Matthews DA, Castriotta Natelson BH. Neuropsychological impairments RJ, Watson RK, Abeles M. Alpha-delta sleep in in chronic fatigue syndrome, multiple sclerosis, patients with a chief complaint of chronic fatigue. and depression. J Neurol Neurosurg Psychiatry 191. Buchwald D, Pascualy R, Bombardier C, Kith P. Sleep disorders in patients with chronic Friedberg F, Coyle PK. Cognitive functioning and fatigue. Clin Infect Dis 1994;18 Suppl 1:S68-72. depression in patients with chronic fatigue 192. Kryger M, Roth T, Dement W. Principles syndrome and multiple sclerosis. Arch Neurol and practice of sleep medicine. 2 ed. PA: WB 193. Swanson J. Sleep disorders sourcebook. Chronic Fatigue Syndrome. In: Straus SE, editor. Chronic Fatigue Syndrome; 1994. p. 405-35. 194. Williams DC. Periodic limb movements of 183. Butler S, Chalder T, Ron M, et al. Cognitive sleep and the restless legs syndrome. Va Med Q behavior therapy in chronic fatigue syndrome. Journal of Neurological Neurosurg Psychiatry 195. Ambrogetti A, Olson LG. Consideration of narcolepsy in the differential diagnosis of chronic 184. Sharpe M. Cognitive - Behavioral Therapy fatigue syndrome. Med J Aust 1994;160:426-9. and the Treatment of Chronic Fatigue. In: Straus 196. Arnold C. Get a good night’s sleep. NY: 185. Prins JB, Bleijenberg G, Bazelmans E, 197. Armstrong S. Melatonin as a chronobiotic Elving LD, de Boo TM, Severens JL, et al. for circadian insomnia: Clinical observations and Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled 198. Nagtegaal JE, Laurant MW, Kerkhof GA, abnormalities demonstrated by home Effects of melatonin on the quality of life in polysomnography in teenagers with chronic patients with delayed sleep phase syndrome. J fatigue syndrome. J Psychosom Res Psychosom Res 2000;48:45-50. 199. Dorn M. [Efficacy and tolerability of 187. Sharpley A, Clements A, Hawton K, Sharpe Baldrian versus oxazepam in non-organic and M. Do patients with “pure” chronic fatigue non-psychiatric insomniacs: a randomised, syndrome (neurasthenia) have abnormal sleep? double-blind, clinical, comparative study]. Forsch Komplementarmed Klass Naturheilkd 188. Morriss RK, Wearden AJ, Battersby L. The relation of sleep difficulties to fatigue, mood and 200. Donath F, Quispe S, Diefenbach K, Maurer disability in chronic fatigue syndrome. J A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and 189. Fischler B, Le Bon O, Hoffmann G, Cluydts sleep quality. Pharmacopsychiatry R, Kaufman L, De Meirleir K. Sleep anomalies in the chronic fatigue syndrome. A comorbidity 201. 5-hydroxytryptophan. Altern Med Rev study. Neuropsychobiology 1997;35:115-22. 202. The Natural Pharmacy Revised: Prima 214. Oberg B, Thoren P. Increased activity in left ventricular receptors during hemorrhage or 203. The A-Z guide to drug, herb and vitamin occlusion of caval veins in the cat. A possible cause of the vaso-vagal reaction. Acta Physiol 204. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating 215. Liu JE, Hahn RT, Stein KM, Markowitz SM, unexplained syncope. Lancet 1986;1:1352-5. Okin PM, Devereux RB, et al. Left ventricular 205. Consensus statement on the definition of geometry and function preceding neurally orthostatic hypotension, pure autonomic failure, mediated syncope. Circulation 2000;101:777-83. and multiple system atrophy. The Consensus 216. Rowell LB, Seals DR. Sympathetic activity Committee of the American Autonomic Society during graded central hypovolemia in hypoxemic humans. Am J Physiol 1990;259:H1197-206. 217. Low PA, Novak V, Spies JM, Novak P, Petty GW. Cerebrovascular regulation in the postural Kapoor WN, Kugler J, Lerman BB, et al. Tilt orthostatic tachycardia syndrome (POTS). Am J table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 207. Syncope: Mechanisms and Management. 208. Kapur WN. Hypotension and Syncope. In: Treatment with the “head-up” bed. JAMA Braunwald, editor. Heart Disease. Philadelphia: 220. Schondorf R, Low PA. Idiopathic postural 209. Reisdorff EJ, Prodinger RJ. Sudden cardiac orthostatic tachycardia syndrome: an attenuated death in the athlete. Emerg Med Clin North Am form of acute pandysautonomia? Neurology 210. Samoil D, Grubb BP, Kip K, Kosinski DJ. 221. Low PA, Opfer-Gehrking TL, Textor SC, Head-upright tilt table testing in children with Benarroch EE, Shen WK, Schondorf R, et al. unexplained syncope. Pediatrics 1993;92:426-30. 211. Lewis T. A lecture on vasovagal syncope and the carotid sinus mechanism: With comments on 222. Grubb BP, Kosinski DJ, Boehm K, Kip K. Gower’s and Nothnagel’s syndrome. Br Med J The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during 212. Gastaut H, Fisher-Williams M. head-up tilt table testing. Pacing Clin Electroencephalographic study of syncope, its differentiation from epilepsy. Lancet 223. Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, et al. Effects 213. Grubb BP, Gerard G, Roush K, of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation H, et al. Differentiation of convulsive syncope and epilepsy with head-up tilt testing. Ann Intern 224. Streeten DH, Anderson GH, Jr., Richardson R, Thomas FD. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intolerance. Clin Auton Res 1999;9:69-73. intact sympathetic nervous function: evidence for 233. Gow BS. Circulatory correlates: vascular excessive venous pooling. J Lab Clin Med impedance, resistance, and capacity. In: Bohr DF, Somlyo AP, Sparks HV, Jr., editors. Handbook of 225. Streeten DH. Pathogenesis of Physiology The Cardiovascular System: Vasc hyperadrenergic orhtostatic hypotension: Smooth Muscle [sect 2, vol II]. Bethesda, MD: Evidence of disoredered venous innervation American Physiologic Society; 1980. p. 353-408. exclusively in the lower limbs. J Clin Invest 234. Rothe CF. Venous system: Physiology of the capacitance vessels. In: Shepherd JT, Abboud FM, 226. Robertson D. The epidemic of orthostatic Geiger SR, editors. Handbook of Physiology The tachycardia and orthostatic intolerance. Am J Med Cardiovascular System: Peripheral Circulation and Organ Blood Flow [sect 22, vol III, part 1]. 227. Patarca R, Klimas NG, Lugtendorf S, Antoni Bethesda, MD: American Physiologic Society; M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue 235. Rowell LB. Human Circulation: Regulation syndrome: interrelations with cellular sources and during Physical Stress. New York: Oxford patterns of soluble immune mediator expression. Clin Infect Dis 1994;18 Suppl 1:S147-53. 228. Stewart J, Weldon A, Arlievsky N, Li K, vascular responses during orthostatic stress in Munoz J. Neurally mediated hypotension and control subjects and patients with posturally autonomic dysfunction measured by heart rate related syncope. Clin Auton Res 2000;10:57-61. variability during head-up tilt testing in children 237. Streeten DH, Anderson GH, Jr. The role of with chronic fatigue syndrome. Clin Auton Res pathogenesis of chronic fatigue. Clin Auton Res 229. Stewart JM, Gewitz MH, Weldon A, Munoz J. Patterns of orthostatic intolerance: the 238. Rowe PC, Bou-Holaigah I, Kan JS, Calkins orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999;135:218-25. unrecognised cause of chronic fatigue? Lancet 230. Stewart JM. Autonomic nervous system dysfunction in adolescents with postural 239. De Lorenzo F, Hargreaves J, Kakkar VV. orthostatic tachycardia syndrome and chronic Possible relationship between chronic fatigue and fatigue syndrome is characterized by attenuated postural tachycardia syndromes. Clin Auton Res vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000;48:218-26. 240. Freeman R, Komaroff AL. Does the chronic 231. Streeten DH, Scullard TF. Excessive fatigue syndromeinvolve the autonomic nervous gravitational blood pooling caused by impaired system? Am J Med 1997;102:357-64. venous tone is the predominant non-cardiac 241. Schondorf R, Freeman R. The importance of mechanism of orthostatic intolerance. Clin Sci orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999;317:117-23. 232. Brown CM, Hainsworth R. Assessment of 242. Grubb BP, Samoil D, Kosinski D, Kip K, capillary fluid shifts during orthostatic stress in Brewster P. Use of sertraline hydrochloride in the normal subjects and subjects with orthostatic treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 252. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus 253. Uvegas JM, Parker JC, Small KL, et al. hypersensitivity unresponsive to dual chamber Psychological symptoms in primary fibromyalgia cardiac pacing. Pacing Clin Electrophysiol syndrome: Relationship to pain, life stress, and sleep disturbance. Arthritis and Rheumatism Komaroff AL. High frequency of fibromyalgia in 254. Wolfe F, Russell IJ, Vipraio G, Ross K, patients with chronic fatigue seen in a primary Anderson J. Serotonin levels, pain threshold, and care practice. Arthritis Rheum 1990;33:381-7. fibromyalgia symptoms in the general population. 245. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence 255. Turk DC, Okifuji A, Sinclair JD, Starz TW. of fibromyalgia. BMJ 1994;309:696-9. Pain, disability, and physical functioning in 246. Wolfe F, Ross K, Anderson J, Russell IJ, subgroups of patients with fibromyalgia. J Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis 256. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. 247. Smith HA. Fibrositis as a disorder of pain Scand J Rheumatol 1986;15:165-73. modulation. Clinics of Rheumatic Diseases 257. Lane RJ, Barrett MC, Woodrow D, Moss J, 248. Wolfe F, Smythe HA, Yunus MB, Bennett characteristics and lactate responses to exercise RM, Bombardier C, Goldenberg DL, et al. The in chronic fatigue syndrome. J Neurol Neurosurg Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. randomized, double-blind, placebo-controlled 249. Russell IJ, Orr MD, Littman B, et al. study of growth hormone in the treatment of Elevated cerebrospianl levels of substance P in fibromyalgia. Am J Med 1998;104:227-31. patients with fibromyalgia syndrome. Arthritis Hernanz-Schulman M, Olsen NJ. Use of P-31 250. Wolfe F. The relation between tender points magnetic resonance spectroscopy to detect and fibromyalgia symptom variables: Evidence metabolic abnormalities in muscles of patients that fibromyalgia is not a discrete disorder in the with fibromyalgia. Arthritis Rheum clinic. Ann Rheum Dis 1997;56:268. 251. Kang Y-K, Russell UJ, Virpaio GA, et al. Low urinary 5-hydroxyindoleacetic acid in Abnormalities in patients with fibromyalgia fibromyalgia syndrome: evidence in support of a syndrome. American Journal of Medical Science serotonin-deficiency pathogenesis. Myalgia 270. Clauw DJ, Heshmat Y, Groner K, et al. Hypothalamic-pituitary-insulin-like growth Heart rate variability as a measure of autonomic factor-I axis dysfunction in patients with function in patients with fibromyalgia. 1996;39. fibromyalgia. J Rheumatol 1997;24:1384-9. 262. Crofford LJ, Demitrack MA. Evidence that Carlsson J. Low growth hormone secretion in abnormalities of central neurohormonal systems patients with fibromyalgia--a preliminary report are key to understanding fibromyalgia and on 10 patients and 10 controls. J Rheumatol chronic fatigue syndrome. Rheum Dis Clin North 272. McCain GA, Bell DA, Mai FM, Halliday 263. Crofford LJ, Engleberg NC, Demitrack MA. PD. A controlled study of the effects of a Neurohormonal perturbations in fibromyalgia. supervised cardiovascular fitness training Baillieres Clin Rheumatol 1996;10:365-78. program on the manifestations of primary 264. Vaeroy H, Helle R, Forre O, Kass E, fibromyalgia. Arthritis Rheum 1988;31:1135-41. Terenius L. Elevated CSF levels of substance P 273. Ferraccioli G, Ghirelli L, Scita F, Nolli M, and high incidence of Raynaud phenomenon in Mozzani M, Fontana S, et al. EMG-biofeedback patients with fibromyalgia: new features for training in fibromyalgia syndrome. J Rheumatol 265. Russell IJ, Fletcher EM, ViVipraio GA, et al. 274. Goldenberg DL, Kaplan KH, Nadeau MG, et Cerebral spinal fluid substance P in fibromyalgia al. A controlled study of a stress-reduction, changes and chronic fatigue syndrome CSFSP cognitive-behavioral treatment program in over time parallel changes in clinical activity. fibromyalgia. J Musculoskel Pain 1994;2:53-66. Journal of Musculoskeletal Pain 1998;6:77. 275. Lichtbroun AS, Smith RB, Mei-Ming CR. 266. Bradley LA, McKendree-Smith NL, Alarcon Cranioelectric Stimulation in FMS. J Clin Rheum GS. Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr Rev Pain 276. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupuncture in fibromyalgia: 267. Bradley LA, Sotolongo A, Alarcon GS, et al. results of a controlled trial. BMJ Dolorimeter stimulation elicits abnormal pain sensitivity and regional cerebral blood flow 277. Bennett RM, Gatter RA, Campbell SM, (rCBF) in the right cingulate cortex (CC) as well as passive coping strategies in non-depressed comparison of cyclobenzaprine and placebo in patients with fibromyalgia (FM). Arthritis and the management of fibrositis. A double-blind controlled study. Arthritis Rheum 268. Mountz JM, Bradley LA, Model JG, et al. 278. Carette S, Bell MJ, Reynolds WJ, Haraoui B, regional cerebral blood flow in the thalmus and McCain GA, Bykerk VP, et al. Comparison of caudate nucleus. Arthritis and Rheumatism amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, 269. Itzhak R, Rosenbaum M, Jochana N, et al. double-blind clinical trial. Arthritis Rheum Cardiovascular response to upright tilt differs in FMS from CFS. Arthritis and Rheumatism 279. Girodano N, Geraci S, Santacroce C, et al. Efficacy and telerability of paroxetine in patients with fibromyalgia syndrome: A single-blind study. community-based study of chronic fatigue Curr Ther Res Clin Exp 1999;60:696-702. syndrome. Arch Intern Med 1999;159:2129-37. 280. Goldenberg DL, Mayskiy M, Mossey CJ, et 290. Harlow BL, Signorello LB, Hall JE, Dailey al. The independent and combined efficacy of C, Komaroff AL. Reproductive correlates of fluoxetine and amitriptyline in the treatment of chronic fatigue syndrome. Am J Med fibromyalgia. Arthritis and Rheumatism 1995;38 291. Reyes M, et al. Risk factors for CFS. J Chronic Fatigue Syndrome 1996;2:17-33. Fibromyalgia: Effects of amitryptyline, 292. Studd J, Panay N. Chronic fatigue syndrome. temazepam and placebo on pain and sleep. Arthritis and Rheumatism 1989;32. 293. Muse KN, et al. The premenstrual syndrome. 282. Vaeroy H, Abrahamsen A, Forre O, Kass E. Effects of ‘medical ovariectomy’. NE Journal of Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, 294. Ashby CR, Jr., Carr LA, Cook CL, Steptoe paracetamol and caffeine (Somadril comp) versus placebo. Clin Rheumatol 1989;8:245-50. 283. Tavoni A, Jeracitano G, Cirigliano G. oxidase activity in premenstrual syndrome. Biol Evaluation of Sadenosylmethionine in secondary fibromyalgia: a double- blind study. Clin Exp Fluoxetine in the treatment of late luteal phase 284. Volkmann H, Norregaard J, Jacobsen S, dysphoric disorder. J Clin Psychiatry Danneskiold-Samsoe B, Knoke G, Nehrdich D. Double-blind, placebo-controlled crossover study 296. Manu P. The pharmacotherapy of common of intravenous S- adenosyl-L-methionine in functional syndromes: Hawthorn Press, Inc.; patients with fibromyalgia. Scand J Rheumatol 297. Chalker L. Interstitial cystitis. The CFIDS 285. Russell IJ, Kamin H, Segar D, et al. Efficacy of Ultram treatment of fibromyalgia syndrome 298. Wookey C. Myalgic Encephalomyelitis: preliminary analysis of a multicenter randomized placebo controlled study. Arthritis and 299. Jessop C. Clinical Features & Possible Etiology of CFIDS. The CFIDS Chronicle; 1991. 286. Bennett R, Silverman S. Bennett & Silverman Debate Opioids: Who Knows Best? 300. Crean EA. CFIDS and Anesthesia: What are Fibromyalgia Network Newsletter; 2000. p. 6-7. the risks? The CFIDS Chronicle; Winter, 2000. p. 287. Kennedy MJ, Goldenberg DL, Felson DT. A perspective longterm study of fibromyalgia. 301. McHaourab A, Mazzeo AJ, May JA, Pagel Arthritis and Rheumatism 1994;S37:S213. PS. Perioperative considerations in a patient with 288. Felson DT, Goldenberg DL. A natural orthostatic intolerance syndrome. Anesthesiology history of fibromyalgia. Arthritis and 2000;93:571-3. 302. Poole J, Herrell R, Ashton S, Goldberg J, 289. Jason LA, Richman JA, Rademaker AW, Buchwald D. Results of isoproterenol tilt table Jordan KM, Plioplys AV, Taylor RR, et al. A testing in monozygotic twins discordant for chronic fatigue syndrome. Arch Intern Med bowel. Aliment Pharmacol Ther 1999;13 Suppl 2000;160:3461-8. 303. Shepherd C. Living with 316. Azpiroz F. Dimensions of gut dysfunction in 304. Ginsburg KS, Kundsin RB, Walter CW, irritable bowel syndrome: altered sensory Schur PH. Ureaplasma urealyticum and function. Can J Gastroenterol 1999;13 Suppl mycoplasma hominis in women with systemic lupus erythematosis. Arthritis and Rheumatism irritable bowel syndrome: literature review and 305. Nelson-Percy C, de Swiet M. hypothesis. Am J Gastroenterol 2000;95:11-6. Corticocosteroids for the Treatment of 318. Moore J, Barlow D, Jewell D, Kennedy S. Hyperemesis Gravidarum. BRit J Obstet & Do gastrointestinal symptoms vary with the menstrual cycle? Br J Obstet Gynaecol 306. Johnson H. Osler’s Web. New York: Crown 319. Krilov LR, Fisher M, Friedman SB, Reitman 307. Gregoire AJP, et al. Transdermal oestrogen is D, Mandel FS. Course and outcome of chronic an effective treatment for severe postnatal fatigue in children and adolescents. Pediatrics depression. Lancet 1996;347:930-33. 308. Freeman RK, Briggs GG, Yaffee SJ. Drugs 320. Rangel L, Garralda ME, Levin M, Roberts H. in Pregnancy and Lactation: A Reference Guide The course of severe chronic fatigue syndrome in to Fetal and Neonatal Risk. 5th ed. Baltimore, childhood. J R Soc Med 2000;93:129-34. MD: Lippincott, Williams & Wilkins; 1998. 321. Garralda E, Rangel L, Levin M, Roberts H, 309. Shepherd C. Living with M.E.: Vermilion; adolescents with a history of chronic fatigue 310. Pimentel M, Chow EJ, Lin HC. Eradication syndrome. J Am Acad Child Adolesc Psychiatry of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J developments: diagnosis and management of 311. American Gastroenterological Association chronic fatigue in children and adolescents. Curr medical position statement: irritable bowel syndrome. Gastroenterology 1997;112:2118-9. 323. Marshall GS, Carger BD. Chronic fatigue 312. Dalton CB, Drossman DA. Diagnosis and syndrome. In: Long SS, Pickering LK, Prober CG, treatment of irritable bowel syndrome. Am Fam editors. Principles and practice of pediatric infectious diseases. NY: Churchill Livingstone; 313. Lashner BA. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am Twelve-year-old girl with chronic fatigue, school 314. Levine JB, Lukawski-Trubish D. absence, and fluctuating somatic symptoms. J Extraintestinal considerations in inflammatory Dev Behav Pediatr 1998;19:196-201. bowel disease. Gastroenterol Clin North Am 325. Fisher G, Straus SE, Oleske JM. Chronic Fatigue Syndrome. New York: Warner Books, 315. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the 326. Lane TJ, Matthews DA, Manu P. The low yield of physical examinations and laboratory Starr SE. Chronic fatigue in children: clinical investigations of patients with chronic fatigue. herpesvirus 6 serology and long term follow-up. 327. Linde A, Andersson B, Svenson SB, Ahrne Pediatr Infect Dis J 1991;10:287-90. H, Carlsson M, Forsberg P, et al. Serum levels of 337. Plioplys AV. Chronic fatigue syndrome lymphokines and soluble cellular receptors in should not be diagnosed in children. Pediatrics primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect 328. Lloyd A, Hickie I, Brockman A, Dwyer J, Postgraduate Medicine 1988;83:69-78. Wakefield D. Cytokine levels in serum and 339. Ayres JG, Flint N, Smith EG, Tunnicliffe WS, cerebrospinal fluid in patients with chronic Fletcher TJ, Hammond K, et al. Post-infection fatigue syndrome and control subjects. J Infect fatigue syndrome following Q fever. Qjm 329. Mawle AC, Nisenbaum R, Dobbins JG, Gary 340. Bruno RL, Creange SJ, Frick NM. Parallels HE, Jr., Stewart JA, Reyes M, et al. Immune between post-polio fatigue and chronic fatigue responses associated with chronic fatigue syndrome: a common pathophysiology? Am J syndrome: a case- control study. J Infect Dis 330. Podell R. “Doctor, why am I so tired?”. NY: Psychosocial risk factors for chronic fatigue and chronic fatigue syndrome following presumed 331. Dobbins JG, Randall B, Reyes M, et al. The viral illness: a case-control study. Psychol Med prevalence of chronic fatiguing illnesses among adolescents in the United States. J Chron Fatigue 342. Diaz-Mitoma F, Vanast WJ, Tyrrell DL. Increased frequency of Epstein-Barr virus 332. Dowsett EG, Colby J. Long-term sickness excretion in patients with new daily persistent epidemiological study with medical and 343. Frick NM, Bruno RL. Post-polio sequelae: educational implications. J Chronic Fatigue physiological and psychological overview. 333. Farmer A, Scourfield J, Martin N, Cardno A, McGuffin P. Is disabling fatigue in childhood McIntosh K. Chronic parvovirus B19 infection influenced by genes? Psychol Med resulting in chronic fatigue syndrome: case history and review. Clin Infect Dis 334. Tomoda A, Miike T, Yamada E, Honda H, Moroi T, Ogawa M, et al. Chronic fatigue 345. Jones JF, et al. Evidence for active syndrome in childhood. Brain Dev 2000;22:60-4. Epstein-Barr virus infection inpatients with 335. DuBois RE, Seeley JK, Brus I, Sakamoto K, persistent, unexlained illness: Elevated anti-early Ballow M, Harada S, et al. Chronic antigen antibodies. Annals of Internal Med mononucleosis syndrome. South Med J 1985;102:1-7. 346. Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, 336. Marshall GS, Gesser RM, Yamanishi K, Yuge K, et al. Antinuclear antibodies in children with chronic nonspecific complaints. syndrome. Arch Dis Child 1998;79:368-74. 358. Schwartz JE, Jandorf L, Krupp LB. The 347. Karas B, Grubb BP, Boehm K, Kip K. The measurement of fatigue: a new instrument. J postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, 359. Wessley S, Chalder T, Hirsch S, et al. exercise intolerance, and cognitive impairment in Psychological symptoms, somatic symptoms, and Pacing Clin Electrophysiol psychiatric disorder in chronic fatigue and chronic fatigue syndrome: A prospective study in 348. Knobeloch L, Jackson R. Recognition of the primary care setting. Am J Psychiatry chronic carbon monoxide poisoning. Wmj 360. Olson GB, Kanaan MN, Gersuk GM, Kelley 349. Kruesi MJ, Dale J, Straus SE. Psychiatric LM, Jones JF. Correlation between allergy and diagnoses in patients who have chronic fatigue persistent Epstein-Barr virus infections in syndrome. J Clin Psychiatry 1989;50:53-6. chronic-active Epstein-Barr virus-infected 350. Lane TJ, Manu P, Matthews DA. Depression patients. J Allergy Clin Immunol 1986;78:308-14. and somatization in the chronic fatigue syndrome. 361. Bobila R, et al. IV gammaglobulin and chroinc Epstein-Barr virus infection. J Allergy 351. Manu P, Matthews DA, Lane TJ. The mental health of patients with a chief complaint of chronic fatigue: A prospective evaluation and controlled trial to assess the eficacy of follow-up. Arch Intern Med 1988;148:2213-7. intravenous gammablobulin for the management 352. Miller HR, Williamson CJ. Coping with of chronic fatigue syndrome in adolescents. J chronic illness. Paper presented at: New Jersey CFS Association Conference, 1998; Long Branch, 363. Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, Tymms K, Wakefield D, Dwyer J, et al. 353. Piper BF, Lindsey AM, Dodd MJ, et al. The Intravenous immunoglobulin is ineffective in the development of an instrument to measure the treatment of patients with chronic fatigue subjective dimension of fatigue. In: Funk S, syndrome. Am J Med 1997;103:38-43. Tournquist, PM, Campagne, MT et al., editor. 364. Fry AM, Martin M. Cognitive idiosyncrasies Mangement of Pain, Fatigue and Nausea. NY: syndrome: anomalies in self-reported activity levels. J Psychosom Res 1996;41:213-23. 365. Hickie I, Lloyd A, Wakefield D, Parker G. Orthostatic intolerance and chronic fatigue The psychiatric status of patients with the chronic syndrome associated with Ehlers-Danlos fatigue syndrome. Br J Psychiatry syndrome. J Pediatr 1999;135:494-9. 355. Marcovitch H. Managing chronic fatigue 366. Hotopf M, Noah N, Wessely S. Chronic syndrome in children. BMJ 1997;314:1635-6. fatigue and minor psychiatric morbidity after 356. Wilson AJ, Hickie I, Lloyd A, et al. The viral meningitis: a controlled study. J Neurol treatment of chronic fatigue syndrome: Science Neurosurg Psychiatry 1996;60:504-9. and speculation. Am J Med 1994;96:544-50. 367. Levine PH. Epidemiologic advances in 357. Wright JB, Beverley DW. Chronic fatigue chronic fatigue syndrome. J Psychiatr Res 368. Pelcovitz D, Septimus A, Friedman SB, Polioencephalitis, stress, and the etiology of Krilov LR, Mandel F, Kaplan S. Psychosocial correlates of chronic fatigue syndrome in adolescent girls. J Dev Behav Pediatr 380. Bruno RL, Sapolsky R, Zimmerman JR, Frick NM. Pathophysiology of a central cause of 369. Ware JE, Jr., Sherbourne CD. The MOS post-polio fatigue. Ann N Y Acad Sci 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med 381. Bruno RL. Predicting hyperactive behavior as a cause of noncompliance with rehabilitation: 370. CFIDS in children Part II: Management of The Reinforcement Motivation Survey. Journal school-related problems. The CFIDS Chronicle; 382. Bruno RL. The psychophysiology of chronic 371. Bell DS. Chronic fatigue syndrome in fatigue in young people. Paper presented at: NIH children and adolescents: A review. Pediatrics State of the Art Workshop, Chronic Fatigue in Adolescents; April, 1998; Washington, DC. 372. Breau LM, McGrath PJ, Ju LH. Review of 383. Ramsay M. Medical Update #1. London: juvenile primary fibromyalgia and chronic fatigue syndrome. J Dev Behav Pediatr 1999;20:278-88. 384. Shepherd C. Pacing and Exercise in Chronic 373. Carter BD, Marshall GS. New Fatigue Syndrome Physiotherapy. Physiotherapy developments: Diagnosis and management of chronic fatigue in children and adolescents. Curr 385. White PD, Naish V. Graded exercise therapy for chronic fatigue syndrome. Physiotherapy Osterman SL, Thurm AE, Jason LA. Chronic 386. Epidemiological study of an epidemic, fatigue syndrome in children and adolescents: a diagnosed as poliomyelitis, occurring among the review. J Adolesc Health 1998;22:4-18. personnel of the Los Angeles County General 375. Kulig J. Advances in medical management Hospital during the summer of 1934. US Public of asthma, headaches, and fatigue. Med Clin 376. Smith DM. Social Security Disability assessment: Inseparable from patient care. Intern Acceptable Sources. 20 CFR. p. 404.1513. Med for the Special 1988;9:51-63. 389. Definition of a Disabling Impairment. 20 377. Bruno RL, Frick NM. Post-Polio Sequelae, CFR. p. 404.1511. 390. Evaluation of a Disability chronic fatigue syndrome and chronic in General. 20 CFR. p. 404.1520. 391. Title II and musculoskeletal pain: Coincidence or causal Title XVI: Evaluation Cases Involving CFS. SSR 378. Bruno RL, Frick NM. The psychology of polio as prelude to postpolio sequelae: behavior modification and psychotherapy. Orthopedic

Source: http://co-cure.org/jp/manual/References.pdf